/head>

No Matches Found

Loading...
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Sangal Papers Reports Strong Q2 FY24-25 Results Amid Long-Term Financial Challenges

Sangal Papers, a microcap in the Paper & Paper Products sector, recently adjusted its evaluation following positive Q2 FY24-25 results, including a significant profit before tax and record net sales. However, the company faces long-term challenges, including a high debt-to-EBITDA ratio and pledged promoter shares.

Feb 10 2025 06:36 PM IST
share
Share Via
Sangal Papers Reports Strong Q2 FY24-25 Results Amid Long-Term Financial Challenges

Sangal Papers Reports Q2 FY24-25 Profit Growth Amid Long-Term Financial Challenges

Sangal Papers, a microcap in the Paper & Paper Products sector, recently adjusted its evaluation following a strong second quarter FY24-25, marked by significant profit growth. However, challenges persist, including weak long-term fundamentals, a high Debt to EBITDA ratio, and a substantial portion of pledged promoter shares.

Feb 03 2025 06:20 PM IST
share
Share Via
Sangal Papers Reports Q2 FY24-25 Profit Growth Amid Long-Term Financial Challenges

Sangal Papers Reports Record Q2 Sales Amid Debt and Pledged Shares Concerns

Sangal Papers, a microcap in the Paper & Paper Products sector, recently adjusted its evaluation based on improved financial metrics. The company reported record net sales of Rs 51.19 crore in Q2 FY24-25, with a PBDIT of Rs 3.33 crore, indicating enhanced operational capacity despite challenges in long-term fundamentals.

Jan 13 2025 06:46 PM IST
share
Share Via
Sangal Papers Reports Record Q2 Sales Amid Debt and Pledged Shares Concerns

Sangal Papers Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators

Sangal Papers has recently undergone a revision in its score by MarketsMOJO, reflecting concerns over its financial health. The company, operating in the Paper & Paper Products sector, has shown weak long-term fundamentals and high debt levels, despite achieving notable quarterly sales. It has been added to MarketsMOJO's list, indicating ongoing scrutiny.

Jan 01 2025 07:40 PM IST
share
Share Via
Sangal Papers Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators

Sangal Papers Experiences Revision in Its Stock Evaluation Amid 52-Week High Achievement

Sangal Papers has reached a new 52-week high, reflecting strong performance in the Paper & Paper Products industry. Following a recent adjustment in its evaluation, the stock has been added to MarketsMOJO's list, highlighting its impressive gains and positive market momentum over the past year.

Dec 17 2024 09:35 AM IST
share
Share Via
Sangal Papers Experiences Revision in Its Stock Evaluation Amid 52-Week High Achievement

Sangal Papers Experiences Revision in Its Stock Evaluation Amid Record High Performance

Sangal Papers has reached an all-time high stock price, reflecting a strong upward trend in its performance metrics. The stock has been added to MarketsMOJO's list following a revision in its score, highlighting its consistent gains and significant outperformance compared to its sector over recent days.

Dec 17 2024 09:25 AM IST
share
Share Via
Sangal Papers Experiences Revision in Its Stock Evaluation Amid Record High Performance

Sangal Papers Reports Positive Financial Results in Q2 of FY 2024-2025

Sangal Papers, a microcap company in the paper and paper products industry, has reported a positive financial performance in the second quarter of fiscal year 2024-2025. The company's PBT, Net Sales, and Operating Profit have all shown significant growth, indicating a positive trend in the near term. However, the company needs to address its Debtors Turnover Ratio to maintain its positive momentum.

Nov 14 2024 09:47 PM IST
share
Share Via
Sangal Papers Reports Positive Financial Results in Q2 of FY 2024-2025

Sangal Papers' Stock Price Surges, Outperforming Sector and Sensex in Impressive Performance

Sangal Papers, a microcap company in the paper and paper products industry, has seen a significant increase in its stock price, hitting a 52-week high of Rs. 324.4 on October 17, 2024. Despite a 'Sell' rating from MarketsMOJO, the company's stock has outperformed the sector and shown positive trends in moving averages and volatility.

Oct 17 2024 09:35 AM IST
share
Share Via
Sangal Papers' Stock Price Surges, Outperforming Sector and Sensex in Impressive Performance

Sangal Papers' Stock Price Surges to All-Time High, Outperforming Sector by 14.16%

Sangal Papers, a microcap company in the paper and paper products industry, has seen a surge in its stock price, reaching an all-time high of Rs. 324.4 on October 17, 2024. Despite a 'Sell' rating from MarketsMOJO, the company's consistent performance and growth potential make it an interesting player in the market.

Oct 17 2024 09:25 AM IST
share
Share Via
Sangal Papers' Stock Price Surges to All-Time High, Outperforming Sector by 14.16%

Sangal Papers' Stock Reaches 52-Week High, Outperforms Sensex in Past Year

Sangal Papers, a microcap company in the paper and paper products industry, has seen a surge in its stock price, reaching a 52-week high of Rs. 310 on September 23, 2024. Despite being rated as a 'Sell' by MarketsMOJO, the stock has shown high volatility and is currently trading above its moving averages. In the past year, it has outperformed the Sensex, indicating potential for growth in the industry.

Sep 23 2024 09:37 AM IST
share
Share Via
Sangal Papers' Stock Reaches 52-Week High, Outperforms Sensex in Past Year

Sangal Papers' Stock Reaches All-Time High Amidst Positive Performance and Industry Challenges

Sangal Papers, a microcap company in the paper and paper products industry, has been in the spotlight as its stock price reached an all-time high on September 23, 2024. Despite a 'Sell' rating from MarketsMOJO, the stock has shown strong performance, outperforming the sector and the Sensex in the past year.

Sep 23 2024 09:35 AM IST
share
Share Via
Sangal Papers' Stock Reaches All-Time High Amidst Positive Performance and Industry Challenges

Sangal Papers' Stock Surges to 52-Week High, Outperforms Sector by 13.32%

Sangal Papers, a microcap company in the paper and paper products industry, has recently seen a surge in its stock price, reaching a 52-week high of Rs 279.85 on September 20, 2024. Despite being rated as a 'Sell' by MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. In the past year, Sangal Papers has shown a strong performance, showcasing its potential for growth in the industry.

Sep 20 2024 01:05 PM IST
share
Share Via
Sangal Papers' Stock Surges to 52-Week High, Outperforms Sector by 13.32%

Sangal Papers downgraded to 'Sell' by MarketsMOJO due to weak fundamentals and high debt levels

Sangal Papers, a microcap company in the paper and paper products industry, has been downgraded to a 'Sell' by MarketsMOJO due to weak fundamental strength, poor long-term growth, and high debt levels. Recent performance has also been flat, with low net sales and a high percentage of pledged promoter shares. While technical indicators show a bullish trend, the stock may not be a good long-term investment option.

Sep 18 2024 06:30 PM IST
share
Share Via
Sangal Papers downgraded to 'Sell' by MarketsMOJO due to weak fundamentals and high debt levels

Sangal Papers Receives 'Hold' Rating from MarketsMOJO Based on Technical Factors, Valuation Remains Attractive

Sangal Papers, a microcap company in the paper and paper products industry, has received a 'Hold' rating from MarketsMOJO due to technical factors such as a bullish stock range and improved trend. However, concerns about long-term fundamentals, high debt, and underperformance in the market should be considered before investing.

Sep 16 2024 06:51 PM IST
share
Share Via
Sangal Papers Receives 'Hold' Rating from MarketsMOJO Based on Technical Factors, Valuation Remains Attractive

Sangal Papers' Stock Surges to 52-Week High, Outperforming Sector and Sensex

Sangal Papers, a microcap company in the paper and paper products industry, has seen a surge in its stock price, reaching a 52-week high of Rs. 279.85 on September 5th, 2024. Despite a 'Sell' rating from MarketsMOJO, the stock has outperformed the sector and the Sensex, showcasing its strong growth potential.

Sep 05 2024 09:35 AM IST
share
Share Via
Sangal Papers' Stock Surges to 52-Week High, Outperforming Sector and Sensex

Sangal Papers Receives 'Sell' Rating from MarketsMOJO Due to Weak Long-Term Outlook

Sangal Papers, a microcap company in the paper and paper products industry, has received a 'Sell' rating from MarketsMOJO due to weak long-term fundamental strength, low ability to service debt, and flat recent performance. However, technically, the stock shows some bullish signs and is currently trading at an attractive valuation. Caution is advised for investors considering this company.

Sep 02 2024 06:12 PM IST
share
Share Via
Sangal Papers Receives 'Sell' Rating from MarketsMOJO Due to Weak Long-Term Outlook

Sangal Papers Receives 'Hold' Rating from MarketsMOJO, Technical Indicators Point to Bullish Outlook

Sangal Papers, a microcap company in the paper and paper products industry, has received a 'Hold' rating from MarketsMOJO on 2024-08-26. The stock is currently in a Bullish range and has shown a positive trend since 22-Aug-24. However, the company's weak long-term fundamentals and high promoter pledged shares suggest a cautious approach towards the stock.

Aug 26 2024 06:36 PM IST
share
Share Via
Sangal Papers Receives 'Hold' Rating from MarketsMOJO, Technical Indicators Point to Bullish Outlook

Sangal Papers downgraded to 'Sell' by MarketsMOJO due to weak performance and high debt

Sangal Papers, a microcap company in the paper and paper products industry, has been downgraded to a 'Sell' by MarketsMOJO due to weak long-term performance, low growth in net sales and operating profit, and a high debt to EBITDA ratio. Recent financial results show a decline and 38.76% of promoter shares are pledged, raising concerns about stock prices. Despite some bullish factors, the stock is currently trading at a discount compared to its historical valuations.

Aug 20 2024 06:51 PM IST
share
Share Via
Sangal Papers downgraded to 'Sell' by MarketsMOJO due to weak performance and high debt

Sangal Papers Receives 'Hold' Rating Amid Bullish Trend and Attractive Valuations

Sangal Papers, a microcap company in the paper and paper products industry, has received a 'Hold' rating from MarketsMOJO due to its bullish trend and attractive valuation. However, the company's long-term fundamental strength is weak with low growth and high debt. Additionally, a significant portion of promoter shares are pledged, which may impact stock prices in a downturn.

Aug 13 2024 06:25 PM IST
share
Share Via
Sangal Papers Receives 'Hold' Rating Amid Bullish Trend and Attractive Valuations

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via